Europe Rat Model Market Size, Share & Forecast by 2022-2028

Europe Rat Model Market Size, Share & Industry Trends Analysis Report By Technology, By Type, By Service, By Application (Toxicology, Oncology, Immunology, and Neurology & Others), By End-use, By Country and Growth Forecast, 2022 - 2028

Published Date: November-2022 | Number of Pages: 104 | Format: PDF | Report ID: KBV-21077

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


COVID-19

Get in-depth analysis of the COVID-19 impact on the Europe Rat Model Market

Market Report Description

The Europe Rat Model Market would witness market growth of 6.7% CAGR during the forecast period (2022-2028).

The laboratory rat has made a vital contribution to cardiovascular medicine, neuronal regeneration, diabetes, wound healing, transplantation, behavioral studies, and research into space motion sickness. In addition, rats have been routinely employed to investigate the efficacy and safety of drugs. The new understanding of the rat genome should lead to improved models in each of these areas of research. Almost all human genes associated with the disease have rat equivalents.

This should help researchers construct genetic models of human disease in rats. In psychology experiments, rats are frequently employed to examine behavior. They have larger brains than mice and are less shy and more intelligent. Although rats do not 'think' like humans, their brain anatomy matches the most rudimentary aspects of human brains; hence, they can be used to imitate certain human actions.

The rat is also a good model for deciphering the biological meaning of QTLs revealed in human genome-wide association studies designed to understand the etiology of prevalent human disorders. These studies identify human genomic areas that control a complicated trait and typically consist of multiple genes; present methods lack the statistical capacity to identify the human causal gene. Each of the rat genes homologous to the human genes found in a given GWAS locus can be knocked out or mutated in a more delicate fashion using an animal model such as the rat. Thus, the potential function of each gene may be examined.

As a result of an increase in the number of research activities that involve the utilization of rodent models, the European rat model market is expanding at an exponential rate. A group of researchers from the Universitat Autonoma de Barcelona (UAB); Spain developed a rat model in September 2021 that was able to recreate the debilitating abnormalities that were identified in patients with Morquio A disease or Mucopolysaccharidosis type IVA.

The Germany market dominated the Europe Rat Model Market by Country in 2021; thereby, achieving a market value of $110 million by 2028. The UK market is exhibiting a CAGR of 5.8% during (2022 - 2028). Additionally, The France market would experience a CAGR of 7.5% during (2022 - 2028).

Based on Technology, the market is segmented into CRISPR/CAS & Others, Nuclear transferase, and Embryonic Stem Cell & Microinjection. Based on Type, the market is segmented into Outbred, Hybrid, Knockout, Inbred, Immunodeficient, and Conditioned. Based on Service, the market is segmented into Breeding, Genetic testing, Cryopreservation, Re-derivation, and Quarantine Depending & Others. Based on Application, the market is segmented into Toxicology, Oncology, Immunology, and Neurology & Others. Based on End-use, the market is segmented into CROs, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Rat Model Market will Hit $1.7 Billion by 2028, at a CAGR of 7.4%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Charles River Laboratories International, Inc., Laboratory Corporation of America Holdings, Inotiv, Inc., genOway, Janvier Labs, Taconic Biosciences, Inc. (H.I.G. Capital), TransViragen, Inc., Biomedical Research Models, Inc. (Biomere) and Cyagen Biosciences.

Scope of the Study

Market Segments Covered in the Report:

By Technology

  • CRISPR/CAS & Others
  • Nuclear transferase
  • Embryonic Stem Cell & Microinjection

By Type

  • Outbred
  • Hybrid
  • Knockout
  • Inbred
  • Immunodeficient
  • Conditioned

By Service

  • Breeding
  • Genetic testing
  • Cryopreservation
  • Re-derivation
  • Quarantine Depending & Others

By Application

  • Toxicology
  • Oncology
  • Immunology
  • Neurology & Others

By End-use

  • CROs
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Charles River Laboratories International, Inc.
  • Laboratory Corporation of America Holdings
  • Inotiv, Inc.
  • genOway
  • Janvier Labs
  • Taconic Biosciences, Inc. (H.I.G. Capital)
  • TransViragen, Inc.
  • Biomedical Research Models, Inc. (Biomere)
  • Cyagen Biosciences

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Rat Model Market Report 2022-2028

North America Rat Model Market Report 2022-2028

Asia Pacific Rat Model Market Report 2022-2028

LAMEA Rat Model Market Report 2022-2028

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities